Diuretic complications

American Journal of the Medical Sciences

Volumn 319, Issue 1, 2000, Pages 10-24

  Greenberg, Arthur ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adverse Effects; Diuretics; Side effects; Toxicity

Indexed keywords

BENDROFLUMETHIAZIDE; CARBONATE DEHYDRATASE INHIBITOR; DIURETIC AGENT; GLUCOSE; LIPID; LOOP DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ARTICLE; CARDIOVASCULAR RISK; DISORDERS OF ACID BASE BALANCE; ELECTROLYTE DISTURBANCE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCALCEMIA; HYPERKALEMIA; HYPERURICEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; KIDNEY CALCIFICATION; MAGNESIUM DEFICIENCY; METABOLIC DISORDER; NEPHROLITHIASIS; OTOTOXICITY; PANCREATITIS;

EID: 0034083082     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9629(15)40676-7     Document Type: Article

References (135)

1. Giebisch G, Malnic G, Berliner RW. Control of renal potassium excretion. In: Brenner BM, Rector FC, editor. Brenner & Rector's the kidney. 4th ed. Philadelphia: W.B. Saunders Company; 1996. p. 371-407.
2. Tannen RL. Diuretic-induced hypokalemia. Kidney Int 1985;28:988-1000.
3. Schwartz WB, Van Ypersele de Strihou C, Kassirer JP. Role of anions in metabolic alkalosis and potassium deficiency. N Engl J Med 1968;279:630-9.
4. Schnaper HW, Freis ED, Friedman RG, et al. Potassium restoration in hypertensive patients made hypokalemic by hydrochlorothiazide. Arch Intern Med 1989;149:2677-81.
5. Toner JM, Ramsay LE. Thiazide-induced hypokalemia; prevalence higher in women. Br J Clin Pharmacol 1984;18: 449-52.
6. Fried TA, Kunau RT. Thiazide diuretics. In: Dirks JH, Sutton RAL, editors. Diuretics. Physiology, pharmacology, and clinical use. Philadelphia: WB Saunders; 1986. p. 66-85.
7. Epstein DL, Grant WM. Carbonic anhydrase inhibitor side effects. Serum chemical analysis. Arch Ophthalmol 1977;95: 1378-82.
8. Widmer P, Maibach R, Kunzi UP, et al. Diuretic-related hypokalaemia: the role of diuretics, potassium supplements, glucocorticoids and beta 2-adrenoceptor agonists. Results from the Comprehensive Hospital Drug Monitoring Programme, Berne (CHDM). Eur J Clin Pharmacol 1995;49: 31-6.
9. Kohvakka A. Maintenance of potassium balance during long-term diuretic therapy in chronic heart failure patients with thiazide-induced-hypokalemia: comparison of potassium supplementation with potassium chloride and potassium-sparing agents, amiloride and triamterene. Int J Clin Pharmacol Ther Toxicol 1988:26:273-7.
10. Maronde RF, Chan LS, Vlachakis N. Hypokalemia in thiazide-treated systemic hypertension. Am J Cardiol 1986; 58:18A-21A.
11. Papademetriou V, Burris J, Kukich S, et al. Effectiveness of potassium chloride or triamterene in thiazide hypokalemia. Arch Intern Med 1985:145:1986-90.
12. Shackleton CR, Wong NLM, Sutton RAL. Distal (potassium-sparing) diuretics. In: Dirks JH, Sutton RAL, editors. Diuretics. Physiology, pharmacology, and clinical use. Philadelphia: WB Saunders; 1986. p. 117-34.
13. Greenblatt DJ, Koch-Weser J. Adverse reactions to spironolactone: a report from the Boston collaborative drug surveillance program. JAMA 1973;225:40-51.
14. Rimmer JM, Horn JF, Gennari FJ. Hyperkalemia as a complication of drug therapy. Arch Intern Med 1987;147:867-9.
15. Acker CG, Johnson JP, Palevsky PM, et al. Hyperkalemia in hospitalized patients: etiology, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 1998;158:917-24.
16. Galla JH, Gifford JD, Luke RG, Rome L. Adaptations to chloride-depletion alkalosis. Am J Physiol 1991;261:R771-81.
17. Alpern RJ, Rector FC Jr. Renal acidification mechanisms. In: Brenner BM, Rector FC, editors. Brenner and Rector's the kidney. 4th ed. Philadelphia: WB Saunders; 1996. p. 408-71.
18. DuBose TD Jr, Cogan MG, Rector FC Jr. Acid-base disorders. In: Brenner BM, Rector FC, editors. Brenner and Rector's the kidney. 4th ed. Philadelphia: WB Saunders; 1996. p. 929-98.
19. Rodman JS, Reidenberg MM. Symptomatic hypokalemia resulting from surreptitious diuretic ingestion. JAMA 1981; 246:1687-9.
20. Heller I, Halevy J, Cohen S, et al. Significant metabolic acidosis induced by acetazolamide. Not a rare complication. Arch Intern Med 1985;145:1815-7.
21. Maisey DN, Brown RD. Acetazolamide and symptomatic metabolic acidosis in mild renal failure. Br Med J (Clin Res Ed) 1981;283:1527-8.
22. Chapron DJ, Gomolin IH, Sweeney KR. Acetazolamide blood concentrations are excessive in the elderly: propensity for acidosis and relationship to renal function. J Clin Pharmacol 1989;29:348-53.
23. Gabow PA, Moore S, Schrier RW. Spironolactone-induced hyperchloremic acidosis in cirrhosis. Ann Intern Med 1979;90:338-40.
24. Ashraf N, Locksley R, Arieff AI. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med 1981;70:1163-8.
25. Friedman E, Shadel M, Halkin H, et al. Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis. Ann Intern Med 1989;110:24-30.
26. Sonnenblick M, Friedlander Y, Rosin AJ. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest 1993;103:601-6.
27. Booker JA. Severe symptomatic hyponatremia in elderly outpatients: the role of thiazide therapy and stress. J Am Geriatr Soc 1984;32:108-13.
28. Abramow M, Cogan E. Clinical aspects and pathophysiology of diuretic-induced hyponatremia. Adv Nephrol Necker Hosp 1984;13:1-28.
29. Shah PJ, Greenberg WM. Water intoxication precipitated by thiazide diuretics in polydipsic psychiatric patients. Am J Psychiatry 1991;148:1424-5.
30. Walters EG, Barnes IC, Price SA, Akbar FA. Hyponatraemia associated with diuretics. Br J Clin Pract 1987; 41:841-4.
31. Ghose RR. Reset osmostat after diuretic treatment. Br Med J 1977;2:1063.
32. Clark BA, Shannon RP, Rosa RM, et al. Increased susceptibility to thiazide-induced hyponatremia in the elderly. J Am Soc Nephrol 1994;5:1106-11.
33. Arieff AI. Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. N Engl J Med 1986;314:1529-35.
34. Berl T. Treating hyponatremia: what is all the controversy about? Ann Intern Med 1990;113:417-9.
35. Brickman AS, Massry SG, Coburn JW. Changes in serum and urinary calcium during treatment with hydrochlorothiazide: studies on mechanisms. J Clin Invest 1972;51:945-54.
36. Costanzo LS, Moses AM, Rao KJ, et al. Dissociation of calcium and sodium clearances in patients with hypoparathyroidism by infusion of chlorothiazide. Metabolism 1975;24:1367-73.
37. Lajeunesse D, Brunette MG. The hypocalciuric effect of thiazides: subcellular localization of the action. Pflugers Arch 1991;417:454-62.
38. Malluche HH, Meyer-Sabellek W, Singer FR, et al. Evidence for a direct effect of thiazides on bone. Miner Electrolyte Metab 1980;4:89-96.
39. Parfitt AM. Thiazide-induced hypercalcemia in vitamin D-treated hypoparathyroidism. Ann Intern Med 1972;77-557-63.
40. Parfitt AM. Chlorothiazide-induced hypercalcemia in juvenile osteoporosis and hyperparathyroidism. N Engl J Med 1969;281:55-9.
41. Quamme GA. Renal magnesium handling: new insights in understanding old problems. Kidney Int 1997;52:1180-95.
42. Davies DL, Fraser R. Do diuretics cause magnesium deficiency? Br J Clin Pharmacol 1993;36:1-10.
43. Ryan MP, Devane J, Ryan MF, et al. Effects of diuretics on the renal handling of magnesium. Drugs 1984;28(Suppl 1):167-81.
44. Dorup I. Magnesium and potassium deficiency. Its diagnosis, occurrence and treatment in diuretic therapy and its consequences for growth, protein synthesis and growth factors. Acta Physiol Scand Suppl 1994;618:1-55.
45. Leary WP, Reyes AJ. Diuretic-induced magnesium losses. Drugs 1984;28(Suppl 1):182-7.
46. Hollifield JW. Magnesium depletion, diuretics, and arrhythmias. Am J Med 1987;82:30-7.
47. Muller JE. Spironolactone in the management of congestive heart failure. Am J Cardiol 1990;65:51K-53K.
48. Bundy JT, Connito D, Mahoney MD, et al. Treatment of idiopathic renal magnesium wasting with amiloride. Am J Nephrol 1995;15:75-7.
49. Sheehan J, White A. Diuretic-associated hypomagnesaemia. Br Med J 1982;285:1157-9.
50. Cocco G, Iselin HU, Strozzi C, et al. Magnesium depletion in patients on long-term chlorthalidone therapy for essential hypertension. Eur J Clin Pharmacol 1987;32:335-8.
51. Carlsen JE, Kober L, Torp-Pedersen C, et al. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. Br Med J 1990;300:975-8.
52. Helgeland A, Hjermann I, Holme I, et al. Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study Am J Med 1978;64:34-8.
53. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension Lancet 1981;2:539-43.
54. Yu T, Berger L, Sarkozi L, et al. Effects of diuretics on urate and calcium excretion. Arch Intern Med 1981;141-915-9.
55. Plante GE, Dessurault DL. Hypertension in elderly patients. A comparative study between indapamide and hydrochlorothiazide. Am J Med 1988;84:98-103.
56. Johnson MW, Mitch WE. The risks of asymptomatic hyperuricaemia and the use of uricosuric diuretics. Drugs 1981;21:220-5.
57. Langford HG, Blaufox MD, Borhani NO, et al. Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program. Arch Intern Med 1987;147:645-9.
58. Gurwitz JH, Kalish SC, Bohn RL, et al. Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol 1997;50:953-9.
59. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
60. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997;277:739-45.
61. MacMahon SW, Cutler JA, Furberg CD, et al. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis 1986;29:99-118.
62. Freis ED. Critique of the clinical importance of diuretic-induced hypokalemia and elevated cholesterol. Arch Intern Med 1989;149:2640-7.
63. Moser M. Critique of the clinical importance of diuretic-induced hypokalemia and elevated cholesterol levels. Arch Intern Med 1990;150:2600, 2603.
64. Kaplan NM. How bad are diuretic-induced hypokalemia and hypercholesterolemia? Arch Intern Med 1989;149:2649.
65. McInnes GT, Yeo WW, Ramsay LE, et al. Cardiotoxicity and diuretics: much speculation-little substance. J Hypertens 1992;10:317-35.
66. Thompson WG. An assault on old friends: thiazide diuretics under siege. Am J Med Sci 1990;300:152-8.
67. Harrington JT, Isner JM, Kassirer JP. Our national obsession with potassium. Am J Med 1982;73:155-9.
68. Helfant RH. Hypokalemia and arrhythmias. Am J Med 1986;80:13-22.
69. Materson BJ. Diuretics, potassium, and ventricular ectopy. Am J Hypertens 1997;10:68S-72S.
70. Freis ED. The efficacy and safety of diuretics in treating hypertension. Ann Intern Med 1995;122:223-6.
71. Shivkumar K, Narins RG. Do diuretics cause heart disease? Ann Intern Med 1995;123:891-2.
72. Ventricular extrasystoles during thiazide treatment: substudy of MRC mild hypertension trial. Br Med J (Clin Res Ed) 1983;287:1249-53.
73. Hollifield JW. Potassium and magnesium abnormalities, diuretics, and arrhythmias in hypertension. Am J Med 1984; 77:28-32.
74. Papademetriou V, Fletcher R, Khatri IM, et al. Diuretic-induced hypokalemia in uncomplicated systemic hypertension: effect of plasma potassium correction on cardiac arrhythmias. Am J Cardiol 1983;52:1017-22.
75. Madias JE, Madias NE, Gavras HP. Nonarrhythmogenicity of diuretic-induced hypokalemia. Arch Intern Med 1984; 144:2171-6.
76. Materson BJ, Caralis PV. Risk of cardiac arrhythmias in relation to potassium imbalance. J Cardiovasc Pharmacol 1984;6:S493-7.
77. Stewart DE, Ikram H, Espiner EA, et al. Arrhythmogenic potential of diuretic induced hypokalaemia in patients with mild hypertension and ischaemic heart disease. Br Heart J 1985;54:290-7.
78. Papademetriou V, Burris JF, Notargiacomo A, et al. Thiazide therapy is not a cause of arrhythmia in patients with systemic hypertension. Arch Intern Med 1988;148: 1272-6.
79. Narayan P, Papademetriou V. Effect of hydrochlorothiazide therapy on cardiac arrhythmias in African-American men with systemic hypertension and moderate to severe left ventricular hypertrophy. Am J Cardiol 1996;78:886-9.
80. Hoes AW, Grobbee DE, Peet TM, Lubsen J. Do nonpotassium-sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidence. Drugs 1994;47:711-33.
81. Siscovick DS, Raghunathan TE, Psaty BM, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994;330:1852-7.
82. Hoes AW, Grobbee DE, Lubsen J, et al. Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med 1995;123:481-7.
83. Bigger JTJ. Diuretic therapy, hypertension, and cardiac arrest. N Engl J Med 1994;330:1899-900.
84. Greenberg G, Brennan PJ, Miall WE. Effects of diuretic and beta-blocker therapy in the Medical Research Council trial. Am J Med 1984;76(Suppl 2A):45-51.
85. Ames RP. The effects of antihypertensive drugs on serum lipids and lipoproteins. Drugs 1986;32:260-78.
86. Morgan TO. Metabolic effects of various anti-hypertensive agents. J Cardiovasc Pharmacol 1990;151(Suppl 5):S39-45.
87. Weidmann P, Uehlinger DE, Gerber A. Antihypertensive treatment and serum lipoproteins. J Hypertens 1985;3: 297-306.
88. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 251:365-374.
89. Grimm RHJ, Flack JM, Grandits GA, et al. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group. JAMA 1996;275:1549-56.
90. Horan MJ. Antihypertensive therapy and atherosclerosis. Am J Med Sci 1991;301:402-5.
91. Weidmann P, de Courten M, Ferrari P, et al. Serum lipoproteins during treatment with antihypertensive drugs. J Cardiovasc Pharmacol 1993;22(Suppl 6):S98-105.
92. Johnson BF. The emerging problem of plasma lipid changes during antihypertensive therapy. J Cardiovasc Pharmacol 1982;4(Suppl 2):S213-21.
93. Monane M, Gurwitz JH, Bohn RL, et al. The impact of thiazide diuretics on the initiation of lipid-reducing agents in older people: a population-based analysis. J Am Geriatr Soc 1997;45:71-5.
94. Ames RP. Hyperlipidemia in hypertension: causes and prevention. Am Heart J 1991;122:1219-24.
95. Moser M. Diuretics and cardiovascular risk factors. Eur Heart J 1992;13(Suppl G):72-80.
96. Weidmann P, de Courten M, Ferrari P. Effect of diuretics on the plasma lipid profile. Eur Heart J 1992;13(Suppl G):61-7.
97. Weinberger MH. Mechanisms of diuretic effects on carbohydrate tolerance, insulin sensitivity and lipid levels. Eur Heart J 1992;13(Suppl G):5-9.
98. Perez-Stable E, Caralis PV. Thiazide-induced disturbances in carbohydrate, lipid, and potassium metabolism. Am Heart J 1983;106:245-51.
99. Lithell HOL. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 1991;14:203-9.
100. Amery A, Berthaux P, Bulpitt C, et al. Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on Hypertension in the Elderly. Lancet 1978;1:681-3.
101. Savage PJ, Pressel SL, Curb JD, et al. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension. Arch Intern Med 1998;158:741-51.
102. Elliott WJ. Glucose and cholesterol elevations during thiazide therapy: intention-to-treat versus actual on-therapy experience. Am J Med 1995;99:261-9.
103. Helgeland A, Leren P, Foss OP, et al. Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study. Am J Med 1984;76:802-5.
104. Skarfors ET, Lithell HO, Selinus I, et al. Do antihypertensive drugs precipitate diabetes in predisposed men? BMJ 1989;298:1147-52.
105. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989;321:868-73.
106. Helderman JH, Elahi D, Andersen DK, et al. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 1983;32:106-11.
107. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46.
108. Rybak LP. Ototoxicity of loop diuretics. Otolaryngol Clin North Am 1993;26:829-44.
109. Seligmann H, Podoshin L, Ben-David J, et al. Drug-induced tinnitus and other hearing disorders. Drug Saf 1996;14:198-212.
110. Dormans TP, Gerlag PG. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure. Eur Heart J 1996;17:1867-74.
111. Gerlag PGG, van Meijel JJM. High-dose furosemide in the treatment of refractory congestive heart failure. Arch Intern Med 1988;148:286-91.
112. Woolfson RG, Mansell MA. Does triamterene cause renal calculi? BMJ 1991;303:1217-8.
113. Ettinger B, Oldroyd NO, Sorgel F. Triamterene nephrolithiasis. JAMA 1980;244:2443-5.
114. Carr MC, Prien ELJ, Babayan RK. Triamterene nephrolithiasis: renewed attention is warranted. J Urol 1990;144: 1339-40.
115. White DJ, Nancollas GH. Triamterene and renal stone formation. J Urol 1982;127:593-7.
116. Jick H, Dinan BJ, Hunter JR. Triamterene and renal stones. J Urol 1982;127:224-5.
117. Hufnagle KG, Khan SN, Penn D, et al. Renal calcifications: a complication of long-term furosemide therapy in preterm infants. Pediatrics 1982;70:360-3.
118. Glasier CM, Stoddard RA, Ackerman NBJ, et al. Nephrolithiasis in infants: association with chronic furosemide therapy. Am J Roentgenol 1983;140:107-8.
119. Alon US, Scagliotti D, Carola RE. Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide. J Pediatr 1994;125:149-51.
120. Tawil R, Moxley RT, Griggs RC. Acetazolamide-induced nephrolithiasis: implications for treatment of neuromuscular disorders. Neurology 1993;43:1105-6.
121. Kass MA, Kolker AE, Gordon M, et al. Acetazolamide and urolithiasis. Ophthalmology 1981;88:261-5.
122. Chang SW, Fine R, Siegel D, et al. The impact of diuretic therapy on reported sexual function. Arch Intern Med 1991; 151:2402-8.
123. Magil AB, Ballon HS, Cameron EC, et al. Acute interstitial nephritis associated with thiazide diuretics. Clinical and pathologic observations in three cases. Am J Med 1980; 69:939-43.
124. Newstead CG, Moore RH, Barnes AJ. Interstitial nephritis associated with indapamide. BMJ 1990;300:1344.
125. Linton AL, Clark WF, Driedger AA, et al. Acute interstitial nephritis due to drugs: Review of the literature with a report of nine cases. Ann Intern Med 1980;93:735-41.
126. Lyons H, Finn VW, Cortell S, et al. Allergic interstitial nephritis causing reversible renal failure in four patients with idiopathic nephrotic syndrome. N Engl J Med 1973; 124-8.
127. Galpin JE, Shinaberger JH, Stanley TM, et al. Acute interstitial nephritis due to methicillin. Am J Med 1978;65: 756-65.
128. Eckhauser ML, Dokler M, Imbembo AL. Diuretic-associated pancreatitis: a collective review and illustrative cases. Am J Gastroenterol 1987;82:865-70.
129. Mallory A, Kern FJ. Drug-induced pancreatitis: a critical review. Gastroenterology 1980;78:813-20.
130. Stenvinkel P, Alvestrand A. Loop diuretic-induced pancreatitis with rechallenge in a patient with malignant hypertension and renal insufficiency. Acta Med Scand 1988; 224:89-91.
131. Fine SR, Lodha A, Zoneraich S, et al. Hydrochlorothiazide-induced acute pulmonary edema. Ann Pharmacother 1995;29:701-3.
132. Howard PA, Dunn MI. Severe musculoskeletal symptoms during continuous infusion of bumetanide. Chest 1997;111: 359-64.
133. Finkle WD, McLaughlin JK, Rasgon SA, et al. Increased risk of renal cell cancer among women using diuretics in the United States. Cancer Causes Control 1993;4:555-8.
134. Weinmann S, Glass AG, Weiss NS, et al. Use of diuretics and other antihypertensive medications in relation to the risk of renal cell cancer. Am J Epidemiol 1994;140:792-804.
135. McLaughlin JK, Chow WH, Mandel JS, et al. International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer 1995;63:216-21.